 James Barry
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Neonatal | 8 | 2025 | 272 | 2.520 |
Why?
| | Patient Safety | 3 | 2025 | 340 | 1.440 |
Why?
| | Intubation, Intratracheal | 3 | 2024 | 313 | 1.350 |
Why?
| | Neonatology | 4 | 2023 | 32 | 1.190 |
Why?
| | Quality Improvement | 4 | 2025 | 1263 | 1.120 |
Why?
| | Bradycardia | 2 | 2024 | 52 | 0.900 |
Why?
| | Laryngoscopy | 1 | 2024 | 123 | 0.780 |
Why?
| | Crime | 1 | 2022 | 60 | 0.730 |
Why?
| | Fetal Growth Retardation | 6 | 2016 | 588 | 0.730 |
Why?
| | Internship and Residency | 4 | 2022 | 1250 | 0.730 |
Why?
| | Physician Executives | 2 | 2019 | 30 | 0.690 |
Why?
| | Patient Discharge | 1 | 2025 | 923 | 0.580 |
Why?
| | Clinical Competence | 5 | 2022 | 1235 | 0.550 |
Why?
| | Professional Role | 1 | 2019 | 167 | 0.540 |
Why?
| | Caregivers | 1 | 2025 | 970 | 0.510 |
Why?
| | Resuscitation | 2 | 2024 | 301 | 0.480 |
Why?
| | Infant, Newborn | 13 | 2026 | 6366 | 0.440 |
Why?
| | Sheep | 7 | 2016 | 885 | 0.430 |
Why?
| | Pediatrics | 2 | 2013 | 1124 | 0.430 |
Why?
| | Glucose | 3 | 2016 | 1042 | 0.420 |
Why?
| | Premedication | 2 | 2024 | 42 | 0.390 |
Why?
| | Delivery Rooms | 1 | 2012 | 10 | 0.370 |
Why?
| | Heart | 1 | 2016 | 632 | 0.360 |
Why?
| | Placental Insufficiency | 2 | 2009 | 126 | 0.320 |
Why?
| | Curriculum | 2 | 2013 | 1047 | 0.300 |
Why?
| | Insulin | 6 | 2016 | 2497 | 0.270 |
Why?
| | Placental Circulation | 1 | 2008 | 71 | 0.270 |
Why?
| | Pregnancy, Animal | 1 | 2007 | 52 | 0.270 |
Why?
| | Myocardium | 2 | 2016 | 928 | 0.250 |
Why?
| | Sheep, Domestic | 1 | 2006 | 34 | 0.240 |
Why?
| | Glucose Transporter Type 4 | 1 | 2006 | 39 | 0.240 |
Why?
| | Glucose Transporter Type 1 | 1 | 2006 | 50 | 0.240 |
Why?
| | Models, Animal | 1 | 2007 | 392 | 0.240 |
Why?
| | Hypoxia | 2 | 2009 | 1177 | 0.210 |
Why?
| | Retinopathy of Prematurity | 1 | 2026 | 174 | 0.200 |
Why?
| | Infant, Extremely Premature | 1 | 2024 | 67 | 0.200 |
Why?
| | Video Recording | 1 | 2024 | 207 | 0.200 |
Why?
| | Retina | 1 | 2026 | 324 | 0.200 |
Why?
| | Artificial Intelligence | 2 | 2024 | 365 | 0.190 |
Why?
| | Fellowships and Scholarships | 2 | 2019 | 333 | 0.190 |
Why?
| | Female | 16 | 2026 | 77251 | 0.170 |
Why?
| | Medical Errors | 1 | 2022 | 123 | 0.170 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2026 | 407 | 0.170 |
Why?
| | Humans | 20 | 2026 | 143560 | 0.160 |
Why?
| | Gestational Age | 5 | 2026 | 970 | 0.160 |
Why?
| | Safety | 1 | 2022 | 357 | 0.160 |
Why?
| | Pregnancy | 8 | 2016 | 7153 | 0.160 |
Why?
| | Guideline Adherence | 1 | 2024 | 574 | 0.150 |
Why?
| | Patient Readmission | 1 | 2025 | 706 | 0.150 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1557 | 0.150 |
Why?
| | Brain Injuries | 1 | 2023 | 506 | 0.140 |
Why?
| | Disease Models, Animal | 2 | 2009 | 4522 | 0.140 |
Why?
| | Infant, Premature | 3 | 2026 | 608 | 0.140 |
Why?
| | Prospective Studies | 4 | 2021 | 7899 | 0.130 |
Why?
| | Sepsis | 1 | 2023 | 638 | 0.130 |
Why?
| | Male | 9 | 2026 | 71500 | 0.130 |
Why?
| | Fetus | 4 | 2009 | 806 | 0.130 |
Why?
| | Students, Medical | 1 | 2022 | 372 | 0.130 |
Why?
| | Amino Acids | 3 | 2009 | 511 | 0.130 |
Why?
| | Glucose Clamp Technique | 1 | 2016 | 198 | 0.110 |
Why?
| | Educational Measurement | 2 | 2022 | 324 | 0.110 |
Why?
| | Obstetrics and Gynecology Department, Hospital | 1 | 2014 | 8 | 0.110 |
Why?
| | Hypertension, Pulmonary | 1 | 2026 | 1957 | 0.110 |
Why?
| | Hospitals, University | 1 | 2014 | 176 | 0.100 |
Why?
| | Inservice Training | 1 | 2014 | 119 | 0.100 |
Why?
| | Infant, Premature, Diseases | 1 | 2014 | 108 | 0.100 |
Why?
| | Delivery, Obstetric | 1 | 2014 | 162 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 301 | 0.090 |
Why?
| | Signal Transduction | 1 | 2006 | 5214 | 0.090 |
Why?
| | Advanced Cardiac Life Support | 1 | 2012 | 25 | 0.090 |
Why?
| | Surgical Procedures, Operative | 1 | 2014 | 274 | 0.090 |
Why?
| | Infant, Small for Gestational Age | 1 | 2012 | 109 | 0.090 |
Why?
| | Competency-Based Education | 1 | 2012 | 83 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2026 | 16741 | 0.080 |
Why?
| | Data Collection | 1 | 2013 | 655 | 0.080 |
Why?
| | Animals | 8 | 2016 | 38010 | 0.080 |
Why?
| | Hospitals, Pediatric | 1 | 2014 | 557 | 0.080 |
Why?
| | Blood Glucose | 3 | 2009 | 2316 | 0.080 |
Why?
| | Receptor, Insulin | 2 | 2007 | 94 | 0.080 |
Why?
| | Organ Size | 2 | 2009 | 481 | 0.070 |
Why?
| | Safety Management | 2 | 2024 | 126 | 0.070 |
Why?
| | Maternal-Fetal Exchange | 1 | 2009 | 170 | 0.070 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2007 | 14 | 0.070 |
Why?
| | Heart Rate | 1 | 2012 | 844 | 0.070 |
Why?
| | United States | 4 | 2024 | 15553 | 0.070 |
Why?
| | Acidosis | 1 | 2009 | 105 | 0.070 |
Why?
| | Lung Diseases | 1 | 2014 | 787 | 0.070 |
Why?
| | Checklist | 2 | 2022 | 106 | 0.070 |
Why?
| | Computer Simulation | 1 | 2012 | 1028 | 0.070 |
Why?
| | Education, Medical, Graduate | 1 | 2012 | 541 | 0.060 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 146 | 0.060 |
Why?
| | Hypoglycemia | 2 | 2009 | 473 | 0.060 |
Why?
| | Glycogen | 1 | 2006 | 56 | 0.060 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2008 | 182 | 0.060 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2006 | 57 | 0.060 |
Why?
| | Oxygen | 2 | 2009 | 998 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6025 | 0.060 |
Why?
| | Regional Blood Flow | 1 | 2008 | 504 | 0.060 |
Why?
| | Blood Pressure | 1 | 2012 | 1755 | 0.060 |
Why?
| | Attitude of Health Personnel | 1 | 2013 | 1207 | 0.060 |
Why?
| | Fever | 1 | 2006 | 310 | 0.050 |
Why?
| | Cerebral Intraventricular Hemorrhage | 1 | 2024 | 5 | 0.050 |
Why?
| | Intensive Care, Neonatal | 1 | 2024 | 40 | 0.050 |
Why?
| | Neonatal Screening | 1 | 2026 | 180 | 0.050 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2006 | 374 | 0.050 |
Why?
| | ROC Curve | 1 | 2026 | 603 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2006 | 441 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2006 | 337 | 0.050 |
Why?
| | Umbilical Cord | 1 | 2024 | 87 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 92 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 471 | 0.050 |
Why?
| | Escherichia | 1 | 2002 | 3 | 0.050 |
Why?
| | Organizational Culture | 1 | 2024 | 162 | 0.050 |
Why?
| | Canada | 1 | 2024 | 433 | 0.050 |
Why?
| | Enterobacteriaceae Infections | 1 | 2002 | 42 | 0.050 |
Why?
| | Meningitis, Bacterial | 1 | 2002 | 46 | 0.050 |
Why?
| | Quality Assurance, Health Care | 1 | 2024 | 322 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2014 | 2887 | 0.040 |
Why?
| | Body Weight | 1 | 2006 | 1003 | 0.040 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2023 | 184 | 0.040 |
Why?
| | Cohort Studies | 1 | 2012 | 5891 | 0.040 |
Why?
| | Infant, Newborn, Diseases | 1 | 2002 | 113 | 0.040 |
Why?
| | Placenta | 1 | 2007 | 770 | 0.040 |
Why?
| | Time Factors | 3 | 2024 | 7031 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2022 | 3380 | 0.040 |
Why?
| | Transcription Factors | 1 | 2007 | 1754 | 0.040 |
Why?
| | Liver | 1 | 2007 | 1864 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2024 | 705 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2008 | 1787 | 0.030 |
Why?
| | Random Allocation | 2 | 2009 | 370 | 0.030 |
Why?
| | Lactic Acid | 2 | 2009 | 308 | 0.030 |
Why?
| | Hemorrhage | 1 | 2002 | 804 | 0.030 |
Why?
| | Middle Aged | 1 | 2019 | 35342 | 0.030 |
Why?
| | Critical Care | 1 | 2022 | 684 | 0.030 |
Why?
| | Blotting, Western | 2 | 2008 | 1223 | 0.030 |
Why?
| | Manikins | 1 | 2014 | 37 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2014 | 279 | 0.020 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 182 | 0.020 |
Why?
| | Infant | 1 | 2026 | 9981 | 0.020 |
Why?
| | Risk Factors | 1 | 2026 | 10644 | 0.020 |
Why?
| | Anesthesiology | 1 | 2014 | 173 | 0.020 |
Why?
| | Survival Rate | 1 | 2014 | 2003 | 0.020 |
Why?
| | Infusion Pumps | 1 | 2009 | 34 | 0.020 |
Why?
| | Infusions, Parenteral | 1 | 2009 | 43 | 0.020 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 25 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 33 | 0.020 |
Why?
| | Somatostatin | 1 | 2008 | 57 | 0.020 |
Why?
| | Patient Care Team | 1 | 2014 | 690 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1824 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2007 | 16 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 151 | 0.020 |
Why?
| | Glucagon | 1 | 2009 | 111 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 24 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2007 | 32 | 0.020 |
Why?
| | Hyperinsulinism | 1 | 2008 | 115 | 0.020 |
Why?
| | Communication | 1 | 2014 | 953 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2844 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 556 | 0.020 |
Why?
| | Carbon Dioxide | 1 | 2009 | 242 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2007 | 537 | 0.020 |
Why?
| | Protein Kinases | 1 | 2008 | 310 | 0.020 |
Why?
| | Fetal Blood | 1 | 2009 | 339 | 0.020 |
Why?
| | Down-Regulation | 1 | 2009 | 644 | 0.020 |
Why?
| | Pancreas | 1 | 2009 | 333 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2936 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2008 | 453 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 994 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2009 | 1091 | 0.010 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2008 | 441 | 0.010 |
Why?
| | Dietary Supplements | 1 | 2009 | 587 | 0.010 |
Why?
| | Up-Regulation | 1 | 2007 | 863 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2012 | 3625 | 0.010 |
Why?
| | Insulin-Secreting Cells | 1 | 2009 | 389 | 0.010 |
Why?
| | Phosphorylation | 1 | 2007 | 1781 | 0.010 |
Why?
| | Child | 1 | 2022 | 22725 | 0.010 |
Why?
| | Algorithms | 1 | 2009 | 1813 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2007 | 2852 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2007 | 2621 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2007 | 2575 | 0.010 |
Why?
|
|
Barry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|